MaxCyte Expects Q1 Sales To Beat Expectations, CFO Resigns
- ByBenzinga-
MaxCyte Inc (NASDAQ: MXCT) appointed Ron Holtz, current Senior Vice President, and Chief Accounting Officer, as the Interim Chief Financial Officer.The change comes as Amanda...